Reducing infection
Most persistent healthcare acquired infections (HCAIs) are due to indwelling medical devices becoming infected, which costs the NHS ~ £1 billion pounds a year in health complications and the negative health outcomes from these infections. Our drug-free approach to antimicrobial surfaces prevents the accumulation of bacteria that lead to infection, without the risks associated with introducing chemicals or metal ions into the body. This safer approach also helps to prevent the wider issue of antimicrobial resistant (AMR) pathogens, which is predicted to cause 10 million deaths by 2050 and seriously undermine many common medical treatments.
